-transparent.png){kind=logo}
The role of tissue CEA localization as a complementary factor in prognosis of patients affected by gastric cancer is analyzed. In a group of 31 gastric tumors, tissue CEA was always present in the apical portion of the tumor cell cytoplasm and in the glandular lumen, while in 23 cases it was found in the stroma, and in superficial and deep cell cytoplasm in 26 and 20 cases respectively. The serum marker levels were over 3 ng/ml in 19 patients. A relationship between CEA localization and tumor stage was observed. The more the tumors were advanced, the more the marker was found in the stroma and in the cytoplasm of superficial and deep cells. The same was found for CEA localization and serum CEA levels. The opposite trend was evidenced for the degree of tumor differentiation. In well differentiated tumors in a high percentage of cases the marker was present in the stroma and in the cytoplasm of superficial and deep cells as compared with undifferentiated tumors. No relationship between the histologic type and CEA localization was found.
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
February 1995,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
September 1989,
Cancer letters,
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
May 2020,
Bosnian journal of basic medical sciences,
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
March 2014,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
January 1994,
Anticancer research,
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
January 1997,
Sao Paulo medical journal = Revista paulista de medicina,
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
November 1993,
Cancer,
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
February 2022,
Irish journal of medical science,
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
May 2011,
Cancer science,
P Barillari, and
P Aurello, and
R De Angelis, and
P Gozzo, and
E Lolli, and
E M Indinnimeo, and
S Brozzetti, and
G Ramacciato, and
S Valabrega, and
G Barillari
December 2003,
Journal of experimental & clinical cancer research : CR,
